20-Jan-2026 3:45 PM CST - Business Wire IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026 IQVIA Holdings Inc. (IQVIA) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its fourth-quarter and full-year 2025 financial results before the market opens on Thursday, February 5, 2026. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time that same day. The earnings release
28-Dec-2025 5:37 AM CST - Yahoo Finance Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)? Let's talk about the popular IQVIA Holdings Inc. . The company's shares saw a significant share price rise of 28% in the past couple of months on the NYSE. The company's trading l
4-Dec-2025 12:49 AM CST - Yahoo Finance Is IQVIA Holdings Stock Outperforming the S&P 500? IQVIA Holdings has significantly outperformed the broader S&P 500 Index in recent months, and analysts remain strongly bullish on the stock's prospects.
19-Nov-2025 12:59 AM CST - Yahoo Finance IQVIA (IQV): Evaluating Valuation Following Third-Quarter Earnings Beat and Upgraded Full-Year Outlook IQVIA Holdings (IQV) just delivered third-quarter earnings and revenue that came in above expectations, providing investors with a bit more optimism around the company's full-year forecast. This earnings update has sparked fresh discussions about the company's outlook.
4-Nov-2025 2:32 AM CST - Yahoo Finance IQVIA's Q3 Earnings Call: Our Top 5 Analyst Questions IQVIA's third quarter results reflected stable operational execution, with revenue and profit slightly ahead of Wall Street expectations. Management identified robust free cash flow generation and a healthy pipeline of clinical trial bookings as primary contributors to the quarter's performance.
3-Nov-2025 1:01 PM CST - Yahoo Finance Why IQVIA (IQV) Shares Are Trading Lower Today Shares of clinical research company IQVIA (NYSE: IQV) fell 2.5% in the afternoon session after TD Cowen downgraded its rating on the stock from Buy to Hold. The firm cited valuation concerns as the main reason for the change,
3-Nov-2025 8:09 AM CST - MSN Iqvia downgraded to Hold from Buy at TD Cowen TD Cowen downgraded Iqvia (IQV) to Hold from Buy with a price target of $215, up from $206. The company's outlook now has "greater visibility and stability," but the stock's current valuation now largely reflects its 2026 growth outlook ...
Latest IQV Trades by Congress Members
15-MAY-2025 - Rob Bresnahan, PA (District 8) sold between $1,001 and $15,000.
20-Jan-2026 3:45 PM CST - Business Wire IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026 IQVIA Holdings Inc. (IQVIA) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its fourth-quarter and full-year 2025 financial results before the market opens on Thursday, February 5, 2026. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time that same day. The earnings release
28-Dec-2025 5:37 AM CST - Yahoo Finance Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)? Let's talk about the popular IQVIA Holdings Inc. . The company's shares saw a significant share price rise of 28% in the past couple of months on the NYSE. The company's trading l
4-Dec-2025 12:49 AM CST - Yahoo Finance Is IQVIA Holdings Stock Outperforming the S&P 500? IQVIA Holdings has significantly outperformed the broader S&P 500 Index in recent months, and analysts remain strongly bullish on the stock's prospects.
19-Nov-2025 12:59 AM CST - Yahoo Finance IQVIA (IQV): Evaluating Valuation Following Third-Quarter Earnings Beat and Upgraded Full-Year Outlook IQVIA Holdings (IQV) just delivered third-quarter earnings and revenue that came in above expectations, providing investors with a bit more optimism around the company's full-year forecast. This earnings update has sparked fresh discussions about the company's outlook.
4-Nov-2025 2:32 AM CST - Yahoo Finance IQVIA's Q3 Earnings Call: Our Top 5 Analyst Questions IQVIA's third quarter results reflected stable operational execution, with revenue and profit slightly ahead of Wall Street expectations. Management identified robust free cash flow generation and a healthy pipeline of clinical trial bookings as primary contributors to the quarter's performance.
3-Nov-2025 1:01 PM CST - Yahoo Finance Why IQVIA (IQV) Shares Are Trading Lower Today Shares of clinical research company IQVIA (NYSE: IQV) fell 2.5% in the afternoon session after TD Cowen downgraded its rating on the stock from Buy to Hold. The firm cited valuation concerns as the main reason for the change,
3-Nov-2025 8:09 AM CST - MSN Iqvia downgraded to Hold from Buy at TD Cowen TD Cowen downgraded Iqvia (IQV) to Hold from Buy with a price target of $215, up from $206. The company's outlook now has "greater visibility and stability," but the stock's current valuation now largely reflects its 2026 growth outlook ...
